Biotechnology
The Biotechnology industry has a total of 670 stocks, with a combined market cap of $1,501.26 billion and total revenue of $121.51 billion.
Market Cap
1,501.26B
Revenue
121.51B
Profits
-33.27B
PE Ratio
n/a
Profit Margin
-27.38%
Dividend Yield
0.09%
670 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 628.28B | -1.68% | 5,900,099 | 35.35B |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 122.26B | 0.54% | 777,937 | 10.19B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 113.21B | -1.17% | 358,412 | 13.10B |
| 4 | MRNA | Moderna, Inc. | 44.87B | 0.97% | 3,355,853 | 5.15B |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.32B | 1.76% | 1,545,864 | 2.00B |
| 6 | ARGX | argenx SE | 25.88B | 0.29% | 286,391 | 39.48M |
| 7 | BNTX | BioNTech SE | 18.72B | -0.09% | 493,767 | 2.97B |
| 8 | GMAB | Genmab A/S | 16.22B | 0.20% | 750,022 | 2.57B |
| 9 | BGNE | BeiGene, Ltd. | 15.83B | -0.66% | 242,433 | 2.76B |
| 10 | BMRN | BioMarin Pharmaceutical Inc. | 15.61B | 0.11% | 1,063,939 | 2.47B |
| 11 | SRPT | Sarepta Therapeutics, Inc. | 14.58B | -1.63% | 1,307,416 | 1.40B |
| 12 | UTHR | United Therapeutics Corporation | 14.07B | -0.61% | 369,808 | 2.50B |
| 13 | INCY | Incyte Corporation | 13.27B | -3.04% | 3,112,659 | 3.77B |
| 14 | RPRX | Royalty Pharma plc | 11.70B | -1.18% | 1,982,304 | 2.24B |
| 15 | TECH | Bio-Techne Corporation | 11.23B | -0.52% | 842,253 | 1.15B |
| 16 | INSM | Insmed Incorporated | 10.40B | -2.77% | 2,511,766 | 315.49M |
| 17 | PCVX | Vaxcyte, Inc. | 8.27B | -1.14% | 494,893 | - |
| 18 | LEGN | Legend Biotech Corporation | 8.16B | -2.78% | 899,053 | 342.80M |
| 19 | ROIV | Roivant Sciences Ltd. | 7.80B | -2.49% | 4,300,333 | 124.80M |
| 20 | ASND | Ascendis Pharma A/S | 7.71B | 1.71% | 243,229 | 357.63M |
| 21 | CERE | Cerevel Therapeutics Holdings, Inc. | 7.51B | -0.29% | 2,053,102 | - |
| 22 | BPMC | Blueprint Medicines Corporation | 6.91B | 1.08% | 477,258 | 282.21M |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 6.63B | -1.30% | 391,701 | 3.84B |
| 24 | IONS | Ionis Pharmaceuticals, Inc. | 6.59B | -4.18% | 1,583,351 | 776.62M |
| 25 | HALO | Halozyme Therapeutics, Inc. | 6.53B | -1.38% | 962,473 | 862.99M |
| 26 | EXEL | Exelixis, Inc. | 6.45B | -0.45% | 868,839 | 1.85B |
| 27 | CYTK | Cytokinetics, Incorporated | 6.29B | 0.26% | 1,140,274 | 3.75M |
| 28 | RVMD | Revolution Medicines, Inc. | 6.17B | -3.68% | 1,101,558 | 4.57M |
| 29 | MDGL | Madrigal Pharmaceuticals, Inc. | 5.79B | -2.74% | 173,397 | - |
| 30 | VKTX | Viking Therapeutics, Inc. | 5.68B | -6.83% | 3,043,220 | - |
| 31 | SMMT | Summit Therapeutics Inc. | 5.29B | -7.37% | 2,665,487 | - |
| 32 | KRYS | Krystal Biotech, Inc. | 5.07B | -2.56% | 266,137 | 95.95M |
| 33 | NUVL | Nuvalent, Inc. | 4.71B | -3.32% | 303,574 | - |
| 34 | BBIO | BridgeBio Pharma, Inc. | 4.66B | -1.15% | 1,472,839 | 218.60M |
| 35 | CRSP | CRISPR Therapeutics AG | 4.51B | -1.55% | 1,057,860 | 271.71M |
| 36 | IBRX | ImmunityBio, Inc. | 4.27B | -1.44% | 1,656,888 | 302.00K |
| 37 | APLS | Apellis Pharmaceuticals, Inc. | 4.25B | -3.61% | 1,465,407 | 524.07M |
| 38 | IMVT | Immunovant, Inc. | 3.88B | -3.60% | 589,768 | - |
| 39 | AXSM | Axsome Therapeutics, Inc. | 3.75B | -2.59% | 409,721 | 251.02M |
| 40 | RNA | Avidity Biosciences, Inc. | 3.71B | -6.01% | 1,369,816 | 10.87M |
| 41 | RARE | Ultragenyx Pharmaceutical Inc. | 3.71B | -0.39% | 763,912 | 442.59M |
| 42 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.59B | -1.15% | 1,234,438 | 1.97M |
| 43 | MRUS | Merus N.V. | 3.52B | -2.50% | 865,556 | 38.34M |
| 44 | DYN | Dyne Therapeutics, Inc. | 3.39B | -2.37% | 775,595 | - |
| 45 | CORT | Corcept Therapeutics Incorporated | 3.29B | -3.40% | 887,610 | 523.53M |
| 46 | ARWR | Arrowhead Pharmaceuticals, Inc. | 3.13B | -3.19% | 789,470 | 35.47M |
| 47 | DNLI | Denali Therapeutics Inc. | 3.10B | -1.23% | 825,276 | 295.39M |
| 48 | BHVN | Biohaven Pharmaceutical Holding Company Ltd. | 3.02B | -3.23% | 1,116,034 | - |
| 49 | FOLD | Amicus Therapeutics, Inc. | 2.92B | 0.51% | 1,046,747 | 423.49M |
| 50 | ACLX | Arcellx, Inc. | 2.85B | -0.65% | 471,078 | 131.66M |
| 51 | TGTX | TG Therapeutics, Inc. | 2.83B | 0.88% | 1,866,327 | 289.33M |
| 52 | SWTX | SpringWorks Therapeutics, Inc. | 2.76B | -3.27% | 768,794 | 26.45M |
| 53 | XENE | Xenon Pharmaceuticals Inc. | 2.76B | -3.00% | 220,639 | - |
| 54 | MOR | MorphoSys AG | 2.73B | -0.33% | 61,140 | 264.75M |
| 55 | ADMA | ADMA Biologics, Inc. | 2.64B | -1.30% | 2,313,385 | 283.18M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 2.62B | -1.25% | 884,068 | 813.81M |
| 57 | RYTM | Rhythm Pharmaceuticals, Inc. | 2.58B | -0.77% | 460,203 | 91.93M |
| 58 | IDYA | IDEAYA Biosciences, Inc. | 2.55B | -6.12% | 841,906 | 15.50M |
| 59 | MLTX | MoonLake Immunotherapeutics | 2.52B | -3.95% | 379,417 | - |
| 60 | GERN | Geron Corporation | 2.47B | -3.92% | 6,071,089 | 520.00K |
| 61 | CLDX | Celldex Therapeutics, Inc. | 2.44B | -5.08% | 652,484 | 6.07M |
| 62 | AGIO | Agios Pharmaceuticals, Inc. | 2.39B | -3.07% | 450,728 | 29.40M |
| 63 | PTCT | PTC Therapeutics, Inc. | 2.33B | -2.50% | 855,715 | 927.56M |
| 64 | GPCR | Structure Therapeutics Inc. | 2.31B | -3.18% | 626,418 | - |
| 65 | APGE | Apogee Therapeutics, Inc. | 2.23B | -0.96% | 314,739 | - |
| 66 | VCEL | Vericel Corporation | 2.19B | 0.09% | 192,940 | 207.78M |
| 67 | IOVA | Iovance Biotherapeutics, Inc. | 2.16B | -4.09% | 4,669,872 | 1.90M |
| 68 | NTLA | Intellia Therapeutics, Inc. | 2.14B | -1.42% | 1,399,195 | 52.60M |
| 69 | FTRE | Fortrea Holdings Inc. | 2.13B | -0.25% | 1,297,356 | 3.01B |
| 70 | CGON | CG Oncology, Inc. | 2.09B | -1.26% | 367,353 | 539.00K |
| 71 | JANX | Janux Therapeutics, Inc. | 2.04B | -5.80% | 434,858 | 7.29M |
| 72 | PTGX | Protagonist Therapeutics, Inc. | 2.03B | -1.73% | 9,682,092 | 314.95M |
| 73 | RXRX | Recursion Pharmaceuticals, Inc. | 1.92B | -4.02% | 5,966,435 | 46.24M |
| 74 | VERA | Vera Therapeutics, Inc. | 1.91B | -3.75% | 322,424 | - |
| 75 | CPRX | Catalyst Pharmaceuticals, Inc. | 1.87B | 0.19% | 738,312 | 411.35M |
| 76 | BEAM | Beam Therapeutics Inc. | 1.86B | -2.08% | 880,753 | 360.91M |
| 77 | KYMR | Kymera Therapeutics, Inc. | 1.85B | -2.36% | 363,160 | 79.41M |
| 78 | NAMS | NewAmsterdam Pharma Company N.V. | 1.83B | -1.36% | 51,520 | - |
| 79 | NVAX | Novavax, Inc. | 1.82B | 1.89% | 3,738,025 | 996.61M |
| 80 | RCKT | Rocket Pharmaceuticals, Inc. | 1.80B | -4.26% | 633,457 | - |
| 81 | SNDX | Syndax Pharmaceuticals, Inc. | 1.76B | -4.04% | 801,454 | - |
| 82 | IMCR | Immunocore Holdings plc | 1.74B | -4.47% | 300,773 | 264.25M |
| 83 | ZLAB | Zai Lab Limited | 1.72B | 0.46% | 281,394 | 291.07M |
| 84 | EWTX | Edgewise Therapeutics, Inc. | 1.72B | -5.16% | 617,254 | - |
| 85 | HRMY | Harmony Biosciences Holdings, Inc. | 1.70B | -1.38% | 508,938 | 617.51M |
| 86 | ARVN | Arvinas, Inc. | 1.70B | -4.35% | 416,486 | 71.30M |
| 87 | GLPG | Galapagos NV | 1.67B | 1.32% | 100,512 | - |
| 88 | MIRM | Mirum Pharmaceuticals, Inc. | 1.59B | -1.41% | 366,585 | 224.00M |
| 89 | KURA | Kura Oncology, Inc. | 1.57B | -2.92% | 673,679 | - |
| 90 | MORF | Morphic Holding, Inc. | 1.57B | -3.90% | 312,113 | - |
| 91 | NMRA | Neumora Therapeutics, Inc. | 1.56B | -1.41% | 865,607 | - |
| 92 | AKRO | Akero Therapeutics, Inc. | 1.55B | -3.37% | 408,069 | - |
| 93 | KROS | Keros Therapeutics, Inc. | 1.54B | -2.19% | 330,056 | 234.00K |
| 94 | LGND | Ligand Pharmaceuticals Incorporated | 1.52B | -0.07% | 115,722 | 118.31M |
| 95 | SLNO | Soleno Therapeutics, Inc. | 1.45B | -6.05% | 1,081,800 | - |
| 96 | MNKD | MannKind Corporation | 1.37B | -1.18% | 1,782,375 | 224.60M |
| 97 | BLTE | Belite Bio, Inc | 1.36B | -0.70% | 33,815 | - |
| 98 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.35B | -1.80% | 2,711,215 | 355.40M |
| 99 | RCUS | Arcus Biosciences, Inc. | 1.33B | -4.25% | 709,587 | 237.00M |
| 100 | KNSA | Kiniksa Pharmaceuticals, Ltd. | 1.31B | 3.72% | 398,893 | 301.77M |
| 101 | IMTX | Immatics N.V. | 1.24B | 0.17% | 333,873 | 80.95M |
| 102 | ARDX | Ardelyx, Inc. | 1.24B | -30.25% | 22,498,343 | 159.11M |
| 103 | IRON | Disc Medicine, Inc. | 1.23B | -10.44% | 514,680 | - |
| 104 | NRIX | Nurix Therapeutics, Inc. | 1.22B | -9.47% | 841,704 | 80.89M |
| 105 | SYRE | Spyre Therapeutics, Inc. | 1.21B | -3.10% | 559,647 | 688.00K |
| 106 | VIR | Vir Biotechnology, Inc. | 1.20B | -2.75% | 962,865 | 79.60M |
| 107 | LBPH | Longboard Pharmaceuticals, Inc. | 1.20B | -0.58% | 1,637,830 | - |
| 108 | SANA | Sana Biotechnology, Inc. | 1.19B | -2.19% | 1,240,840 | - |
| 109 | DAWN | Day One Biopharmaceuticals, Inc. | 1.18B | -0.88% | 719,272 | - |
| 110 | VRNA | Verona Pharma plc | 1.17B | -0.32% | 1,043,562 | - |
| 111 | XNCR | Xencor, Inc. | 1.13B | -4.00% | 390,571 | 162.18M |
| 112 | PRTA | Prothena Corporation plc | 1.10B | -0.44% | 330,454 | 89.25M |
| 113 | ARQT | Arcutis Biotherapeutics, Inc. | 1.08B | -2.72% | 1,919,814 | 106.39M |
| 114 | FDMT | 4D Molecular Therapeutics, Inc. | 1.06B | -3.56% | 386,749 | 20.45M |
| 115 | TARS | Tarsus Pharmaceuticals, Inc. | 1.04B | -2.44% | 844,634 | 42.56M |
| 116 | CALT | Calliditas Therapeutics AB (publ) | 1.04B | 0.83% | 5,604 | 119.73M |
| 117 | OCUL | Ocular Therapeutix, Inc. | 1.03B | 0.30% | 2,399,316 | 59.84M |
| 118 | GYRE | Gyre Therapeutics, Inc. | 1.03B | 0.33% | 48,124 | 140.62M |
| 119 | INVA | Innoviva, Inc. | 1.03B | - | 298,757 | 311.59M |
| 120 | ELVN | Enliven Therapeutics, Inc. | 1.02B | -4.41% | 133,757 | - |
| 121 | MDXG | MiMedx Group, Inc. | 1.00B | 1.19% | 572,999 | 334.51M |
| 122 | CGEM | Cullinan Oncology, Inc. | 940.01M | -2.51% | 475,840 | - |
| 123 | MRVI | Maravai LifeSciences Holdings, Inc. | 908.56M | -1.44% | 1,884,303 | 274.10M |
| 124 | PHVS | Pharvaris N.V. | 906.81M | -9.84% | 78,613 | - |
| 125 | LQDA | Liquidia Corporation | 903.98M | -1.74% | 534,502 | 15.97M |
| 126 | AUTL | Autolus Therapeutics plc | 899.20M | -2.59% | 1,545,742 | 10.50M |
| 127 | RAPP | Rapport Therapeutics, Inc. | 884.77M | -1.69% | 198,389 | - |
| 128 | CNTA | Centessa Pharmaceuticals plc | 881.23M | -0.34% | 215,425 | 6.85M |
| 129 | TYRA | Tyra Biosciences, Inc. | 876.32M | -3.36% | 124,063 | - |
| 130 | SLN | Silence Therapeutics plc | 873.92M | -3.63% | 298,217 | 33.86M |
| 131 | TNGX | Tango Therapeutics, Inc. | 865.99M | -9.94% | 791,878 | 37.23M |
| 132 | RLAY | Relay Therapeutics, Inc. | 858.84M | 1.09% | 3,002,135 | 35.33M |
| 133 | ABVX | Abivax SA | 849.39M | -0.44% | 37,025 | 5.13M |
| 134 | BCYC | Bicycle Therapeutics plc | 844.55M | -2.37% | 269,895 | 41.61M |
| 135 | SPRY | ARS Pharmaceuticals, Inc. | 839.11M | -0.80% | 547,997 | 10.00K |
| 136 | ABCL | AbCellera Biologics Inc. | 814.53M | -0.36% | 2,134,955 | 35.79M |
| 137 | COGT | Cogent Biosciences, Inc. | 787.85M | -7.83% | 816,629 | - |
| 138 | AUPH | Aurinia Pharmaceuticals Inc. | 776.59M | -1.09% | 555,809 | 191.41M |
| 139 | VRDN | Viridian Therapeutics, Inc. | 776.08M | -7.95% | 508,681 | 288.00K |
| 140 | DNTH | Dianthus Therapeutics, Inc. | 771.01M | -9.01% | 251,667 | 2.26M |
| 141 | DNA | Ginkgo Bioworks Holdings, Inc. | 766.21M | 7.21% | 68,839,253 | 208.70M |
| 142 | CVAC | CureVac N.V. | 749.18M | 0.30% | 670,907 | 64.13M |
| 143 | ETNB | 89bio, Inc. | 747.72M | -2.06% | 897,535 | - |
| 144 | NUVB | Nuvation Bio Inc. | 736.57M | -5.70% | 1,426,057 | - |
| 145 | MESO | Mesoblast Limited | 736.10M | -4.87% | 240,030 | 7.25M |
| 146 | CRGX | CARGO Therapeutics, Inc. | 725.99M | -1.06% | 247,062 | - |
| 147 | HLVX | HilleVax, Inc. | 710.02M | -0.97% | 153,192 | - |
| 148 | IMNM | Immunome, Inc. | 701.64M | -4.10% | 597,611 | 12.68M |
| 149 | ALMS | Alumis Inc. | 673.05M | -4.78% | 280,953 | - |
| 150 | PRAX | Praxis Precision Medicines, Inc. | 671.83M | -4.66% | 311,089 | 2.20M |
| 151 | STOK | Stoke Therapeutics, Inc. | 668.71M | -7.50% | 542,610 | 7.85M |
| 152 | ANAB | AnaptysBio, Inc. | 654.01M | -2.72% | 245,929 | 22.96M |
| 153 | SAGE | Sage Therapeutics, Inc. | 651.17M | -1.90% | 780,500 | 91.06M |
| 154 | EXAI | Exscientia plc | 644.10M | -0.97% | 297,010 | 25.14M |
| 155 | PLRX | Pliant Therapeutics, Inc. | 639.45M | -2.39% | 409,491 | 248.00K |
| 156 | PROK | ProKidney Corp. | 639.34M | -10.40% | 880,375 | - |
| 157 | WVE | Wave Life Sciences Ltd. | 639.32M | -0.29% | 895,822 | 112.91M |
| 158 | PRME | Prime Medicine, Inc. | 633.76M | -3.65% | 532,431 | 591.00K |
| 159 | URGN | UroGen Pharma Ltd. | 622.71M | -8.13% | 539,955 | 84.30M |
| 160 | GHRS | GH Research PLC | 619.65M | 1.36% | 23,979 | - |
| 161 | AVBP | ArriVent BioPharma, Inc. | 616.62M | 1.43% | 44,132 | - |
| 162 | TVTX | Travere Therapeutics, Inc. | 615.88M | -2.29% | 628,873 | 183.23M |
| 163 | SRRK | Scholar Rock Holding Corporation | 608.52M | -6.15% | 514,330 | - |
| 164 | HUMA | Humacyte, Inc. | 608.52M | -4.84% | 3,257,561 | - |
| 165 | ERAS | Erasca, Inc. | 602.84M | -4.92% | 1,221,160 | - |
| 166 | MLYS | Mineralys Therapeutics, Inc. | 600.25M | -0.66% | 182,605 | - |
| 167 | PHAT | Phathom Pharmaceuticals, Inc. | 599.99M | -5.18% | 601,869 | 2.59M |
| 168 | SVRA | Savara Inc. | 594.21M | -7.33% | 2,163,723 | - |
| 169 | ZYME | Zymeworks Inc. | 593.92M | -2.44% | 349,889 | 50.46M |
| 170 | ABUS | Arbutus Biopharma Corporation | 590.68M | 0.32% | 856,347 | 12.99M |
| 171 | OLMA | Olema Pharmaceuticals, Inc. | 582.27M | -6.55% | 689,406 | - |
| 172 | ARCT | Arcturus Therapeutics Holdings Inc. | 578.50M | -9.21% | 1,327,238 | 124.53M |
| 173 | LXRX | Lexicon Pharmaceuticals, Inc. | 578.39M | -4.48% | 1,750,049 | 2.31M |
| 174 | CELC | Celcuity Inc. | 568.29M | -2.70% | 335,339 | - |
| 175 | SAVA | Cassava Sciences, Inc. | 565.64M | -2.88% | 2,809,654 | - |
| 176 | PRTC | PureTech Health plc | 551.53M | 5.22% | 342 | 3.33M |
| 177 | PHAR | Pharming Group N.V. | 542.12M | 0.50% | 1,316 | 280.83M |
| 178 | CTNM | Contineum Therapeutics, Inc. | 532.22M | -1.48% | 194,016 | 50.00M |
| 179 | RGNX | REGENXBIO Inc. | 529.50M | -2.89% | 481,493 | 86.73M |
| 180 | PEPG | PepGen Inc. | 529.05M | -8.88% | 82,863 | - |
| 181 | ITOS | iTeos Therapeutics, Inc. | 521.61M | -3.80% | 268,826 | - |
| 182 | TRDA | Entrada Therapeutics, Inc. | 519.76M | -2.23% | 58,599 | 162.87M |
| 183 | REPL | Replimune Group, Inc. | 514.04M | -10.58% | 919,691 | - |
| 184 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 513.07M | -2.81% | 181,701 | - |
| 185 | ORIC | ORIC Pharmaceuticals, Inc. | 507.02M | -1.57% | 529,340 | - |
| 186 | VALN | Valneva SE | 504.43M | 2.25% | 5,424 | 166.26M |
| 187 | THRD | Third Harmonic Bio, Inc. | 501.22M | -5.04% | 49,530 | - |
| 188 | NGNE | Neurogene Inc. | 499.22M | -5.32% | 299,741 | - |
| 189 | YMAB | Y-mAbs Therapeutics, Inc. | 498.95M | -3.89% | 371,047 | 84.50M |
| 190 | APLT | Applied Therapeutics, Inc. | 497.06M | -5.64% | 711,032 | -477.00K |
| 191 | ADPT | Adaptive Biotechnologies Corporation | 496.63M | -6.39% | 1,171,858 | 174.50M |
| 192 | ATXS | Astria Therapeutics, Inc. | 492.57M | -3.03% | 386,577 | - |
| 193 | LRMR | Larimar Therapeutics, Inc. | 491.91M | -6.43% | 356,318 | - |
| 194 | MNMD | Mind Medicine (MindMed) Inc. | 490.69M | -1.56% | 733,303 | - |
| 195 | OCS | Oculis Holding AG | 487.89M | -0.25% | 15,262 | 995.46K |
| 196 | KALV | KalVista Pharmaceuticals, Inc. | 485.59M | -3.20% | 248,335 | - |
| 197 | MREO | Mereo BioPharma Group plc | 483.93M | -4.96% | 930,444 | - |
| 198 | ANNX | Annexon, Inc. | 481.21M | -9.60% | 1,387,590 | - |
| 199 | ALT | Altimmune, Inc. | 477.88M | -6.39% | 3,449,466 | 410.00K |
| 200 | LXEO | Lexeo Therapeutics, Inc. | 461.89M | -10.19% | 402,663 | - |
| 201 | ALLO | Allogene Therapeutics, Inc. | 450.97M | -7.30% | 3,052,271 | 65.00K |
| 202 | LENZ | LENZ Therapeutics, Inc. | 447.88M | -0.85% | 250,574 | - |
| 203 | TSHA | Taysha Gene Therapies, Inc. | 434.98M | -4.42% | 1,941,852 | 14.16M |
| 204 | TERN | Terns Pharmaceuticals, Inc. | 434.63M | -1.90% | 1,323,646 | - |
| 205 | OABI | OmniAb, Inc. | 429.85M | -1.87% | 798,606 | 21.05M |
| 206 | CDMO | Avid Bioservices, Inc. | 425.31M | -5.90% | 752,009 | 136.74M |
| 207 | VERV | Verve Therapeutics, Inc. | 419.83M | 0.40% | 1,188,214 | 16.05M |
| 208 | ALEC | Alector, Inc. | 418.31M | -1.81% | 293,790 | 96.41M |
| 209 | EYPT | EyePoint Pharmaceuticals, Inc. | 417.20M | -3.61% | 803,221 | 50.02M |
| 210 | OCGN | Ocugen, Inc. | 414.34M | -0.92% | 5,846,098 | 7.05M |
| 211 | VYGR | Voyager Therapeutics, Inc. | 412.85M | -3.44% | 335,985 | 119.04M |
| 212 | HRTX | Heron Therapeutics, Inc. | 412.79M | -21.04% | 7,493,670 | 132.10M |
| 213 | SLRN | Acelyrin, Inc. | 407.99M | -2.83% | 308,916 | - |
| 214 | TBPH | Theravance Biopharma, Inc. | 404.63M | -2.35% | 160,040 | 61.51M |
| 215 | ENGN | enGene Holdings Inc. | 397.05M | -0.66% | 76,890 | - |
| 216 | LYEL | Lyell Immunopharma, Inc. | 384.96M | -4.43% | 934,666 | 68.00K |
| 217 | ACIU | AC Immune SA | 383.90M | -2.76% | 165,889 | 16.82M |
| 218 | FULC | Fulcrum Therapeutics, Inc. | 379.14M | -3.33% | 521,268 | 2.51M |
| 219 | IGMS | IGM Biosciences, Inc. | 377.75M | -5.74% | 134,281 | 2.11M |
| 220 | PGEN | Precigen, Inc. | 376.11M | -3.87% | 776,268 | 5.44M |
| 221 | EDIT | Editas Medicine, Inc. | 373.36M | -1.52% | 1,542,508 | 69.41M |
| 222 | NKTX | Nkarta, Inc. | 370.66M | -10.09% | 564,409 | - |
| 223 | FATE | Fate Therapeutics, Inc. | 366.54M | -1.23% | 1,111,497 | 6.48M |
| 224 | CABA | Cabaletta Bio, Inc. | 356.76M | -5.38% | 842,674 | - |
| 225 | AURA | Aura Biosciences, Inc. | 354.23M | -2.99% | 69,889 | - |
| 226 | AVXL | Anavex Life Sciences Corp. | 349.57M | 0.49% | 555,928 | - |
| 227 | KYTX | Kyverna Therapeutics, Inc. | 347.08M | 3.07% | 624,146 | - |
| 228 | JSPR | Jasper Therapeutics, Inc. | 343.65M | -1.56% | 94,903 | - |
| 229 | ABSI | Absci Corporation | 335.86M | -1.33% | 829,231 | 5.35M |
| 230 | ADCT | ADC Therapeutics SA | 334.87M | -5.43% | 486,707 | 68.62M |
| 231 | TRML | Tourmaline Bio, Inc. | 321.86M | -1.49% | 330,114 | - |
| 232 | VRCA | Verrica Pharmaceuticals Inc. | 316.88M | -6.04% | 145,671 | 8.91M |
| 233 | CCCC | C4 Therapeutics, Inc. | 311.00M | -6.80% | 1,338,506 | 20.04M |
| 234 | KRRO | Korro Bio, Inc. | 307.03M | -2.19% | 102,022 | - |
| 235 | VNDA | Vanda Pharmaceuticals Inc. | 306.71M | -5.56% | 1,289,125 | 177.60M |
| 236 | XERS | Xeris Biopharma Holdings, Inc. | 305.41M | -5.07% | 1,368,880 | 171.36M |
| 237 | TCRX | TScan Therapeutics, Inc. | 302.90M | -3.37% | 483,502 | 14.81M |
| 238 | FHTX | Foghorn Therapeutics Inc. | 300.99M | -6.85% | 101,217 | 33.90M |
| 239 | AGEN | Agenus Inc. | 299.87M | -14.44% | 668,628 | 161.42M |
| 240 | ANRO | Alto Neuroscience, Inc. | 298.41M | -2.63% | 49,455 | - |
| 241 | RNAC | Cartesian Therapeutics, Inc. | 298.08M | -35.02% | 1,443,503 | 25.91M |
| 242 | ALXO | ALX Oncology Holdings Inc. | 298.01M | -4.51% | 460,132 | - |
| 243 | PSTX | Poseida Therapeutics, Inc. | 292.81M | 0.33% | 454,232 | 82.50M |
| 244 | OPT | Opthea Limited | 287.35M | 0.79% | 25,945 | 385.28K |
| 245 | XOMA | XOMA Corporation | 286.78M | -1.04% | 7,002 | 5.81M |
| 246 | ENTA | Enanta Pharmaceuticals, Inc. | 284.86M | 2.91% | 76,693 | 72.88M |
| 247 | NAUT | Nautilus Biotechnology, Inc. | 284.35M | - | 45,188 | - |
| 248 | INZY | Inozyme Pharma, Inc. | 273.40M | 0.23% | 500,285 | - |
| 249 | AVIR | Atea Pharmaceuticals, Inc. | 272.04M | -4.15% | 226,867 | - |
| 250 | OBIO | Orchestra BioMed Holdings, Inc. | 266.27M | 4.49% | 35,880 | 2.22M |
| 251 | MGNX | MacroGenics, Inc. | 256.80M | -4.65% | 887,192 | 43.36M |
| 252 | IMMP | Immutep Limited | 256.61M | -6.47% | 302,616 | 4.58M |
| 253 | ZNTL | Zentalis Pharmaceuticals, Inc. | 253.52M | -14.80% | 1,296,751 | 40.56M |
| 254 | MGTX | MeiraGTx Holdings plc | 253.37M | -3.90% | 115,165 | 697.00K |
| 255 | RVNC | Revance Therapeutics, Inc. | 252.76M | -5.84% | 1,182,725 | 236.65M |
| 256 | NBTX | Nanobiotix S.A. | 246.86M | 0.77% | 696 | 40.23M |
| 257 | ADAP | Adaptimmune Therapeutics plc | 246.73M | - | 1,611,850 | 18.36M |
| 258 | STRO | Sutro Biopharma, Inc. | 242.11M | -2.95% | 615,804 | 154.07M |
| 259 | RENB | Renovaro Biosciences Inc. | 238.59M | -0.64% | 341,115 | - |
| 260 | BDTX | Black Diamond Therapeutics, Inc. | 236.82M | -10.43% | 522,880 | - |
| 261 | TNYA | Tenaya Therapeutics, Inc. | 233.59M | -11.72% | 361,388 | - |
| 262 | TECX | Tectonic Therapeutic Inc. | 233.39M | -0.38% | 54,765 | - |
| 263 | MOLN | Molecular Partners AG | 232.27M | -2.78% | 40,129 | 7.64M |
| 264 | SLDB | Solid Biosciences Inc. | 228.74M | -4.94% | 661,223 | - |
| 265 | MRSN | Mersana Therapeutics, Inc. | 227.59M | -5.58% | 964,679 | 38.30M |
| 266 | CRMD | CorMedix Inc. | 226.43M | -3.74% | 428,561 | - |
| 267 | GLSI | Greenwich LifeSciences, Inc. | 226.43M | 4.83% | 62,679 | - |
| 268 | CBUS | Cibus, Inc. | 226.16M | -6.36% | 167,736 | 2.32M |
| 269 | OMER | Omeros Corporation | 223.09M | -2.53% | 126,547 | - |
| 270 | GLUE | Monte Rosa Therapeutics, Inc. | 219.53M | -8.88% | 290,610 | 1.06M |
| 271 | EPIX | ESSA Pharma Inc. | 218.71M | -3.71% | 30,356 | - |
| 272 | ZURA | Zura Bio Limited | 218.44M | -5.51% | 393,476 | - |
| 273 | INO | Inovio Pharmaceuticals, Inc. | 218.43M | -2.09% | 304,156 | 717.07K |
| 274 | ATAI | Atai Life Sciences N.V. | 217.63M | -3.70% | 538,450 | 277.00K |
| 275 | GOSS | Gossamer Bio, Inc. | 217.12M | 1.29% | 1,642,553 | - |
| 276 | RZLT | Rezolute, Inc. | 216.34M | -2.32% | 259,509 | - |
| 277 | QTTB | Q32 Bio Inc. | 215.55M | -4.90% | 95,255 | 354.00K |
| 278 | NKTR | Nektar Therapeutics | 215.30M | -4.10% | 1,429,858 | 90.17M |
| 279 | GUTS | Fractyl Health, Inc. | 212.66M | -0.45% | 96,603 | 148.00K |
| 280 | SKYE | Skye Bioscience, Inc. | 212.19M | -6.20% | 132,004 | - |
| 281 | ATNM | Actinium Pharmaceuticals, Inc. | 207.29M | -3.33% | 179,884 | 81.00K |
| 282 | PRLD | Prelude Therapeutics Incorporated | 204.89M | -1.06% | 9,670 | - |
| 283 | CDXS | Codexis, Inc. | 203.91M | -3.34% | 231,261 | 74.23M |
| 284 | ELYM | Eliem Therapeutics, Inc. | 202.61M | -3.40% | 93,330 | - |
| 285 | CYBN | Cybin Inc. | 201.24M | -0.04% | 3,340,898 | - |
| 286 | AKBA | Akebia Therapeutics, Inc. | 201.21M | -3.46% | 3,294,237 | 187.23M |
| 287 | TSVT | 2seventy bio, Inc. | 198.42M | -4.69% | 271,546 | 71.20M |
| 288 | GNFT | Genfit S.A. | 197.54M | -0.50% | 4,944 | 42.42M |
| 289 | INBX | Inhibrx, Inc. | 196.29M | -1.31% | 170,720 | - |
| 290 | RANI | Rani Therapeutics Holdings, Inc. | 195.12M | 1.31% | 15,417 | - |
| 291 | CDXC | ChromaDex Corporation | 194.89M | -4.09% | 232,484 | 83.17M |
| 292 | QURE | uniQure N.V. | 194.68M | -9.79% | 1,111,740 | 19.00M |
| 293 | ALDX | Aldeyra Therapeutics, Inc. | 193.10M | - | 237,387 | - |
| 294 | TRVI | Trevi Therapeutics, Inc. | 188.77M | -7.27% | 143,557 | - |
| 295 | ACRV | Acrivon Therapeutics, Inc. | 187.73M | 3.75% | 94,779 | - |
| 296 | IPSC | Century Therapeutics, Inc. | 186.75M | -8.30% | 142,578 | 1.37M |
| 297 | CADL | Candel Therapeutics, Inc. | 185.98M | -0.79% | 517,904 | - |
| 298 | ZVRA | Zevra Therapeutics, Inc. | 182.48M | -3.33% | 228,378 | 28.01M |
| 299 | DSGN | Design Therapeutics, Inc. | 180.78M | -1.54% | 145,853 | - |
| 300 | BLUE | bluebird bio, Inc. | 177.92M | -5.35% | 4,459,392 | 21.73M |
| 301 | LCTX | Lineage Cell Therapeutics, Inc. | 176.00M | -2.31% | 526,149 | 8.00M |
| 302 | XBIT | XBiotech Inc. | 173.30M | 2.52% | 171,149 | - |
| 303 | PYXS | Pyxis Oncology, Inc. | 173.13M | -8.13% | 890,671 | 16.15M |
| 304 | STTK | Shattuck Labs, Inc. | 173.09M | -8.77% | 385,895 | 2.72M |
| 305 | ABEO | Abeona Therapeutics Inc. | 168.77M | -1.90% | 153,633 | 3.50M |
| 306 | IPHA | Innate Pharma S.A. | 166.75M | -0.96% | 155 | 68.49M |
| 307 | OTLK | Outlook Therapeutics, Inc. | 165.95M | -4.32% | 99,287 | - |
| 308 | FENC | Fennec Pharmaceuticals Inc. | 164.75M | -3.83% | 56,012 | 44.95M |
| 309 | INMB | INmune Bio, Inc. | 159.64M | -4.16% | 152,497 | 131.00K |
| 310 | CHRS | Coherus BioSciences, Inc. | 159.47M | -13.66% | 3,919,780 | 301.87M |
| 311 | BMEA | Biomea Fusion, Inc. | 159.23M | 0.23% | 699,038 | - |
| 312 | MGX | Metagenomi, Inc. | 158.47M | -4.30% | 39,325 | 47.26M |
| 313 | ACHV | Achieve Life Sciences, Inc. | 157.63M | -3.97% | 153,798 | - |
| 314 | GBIO | Generation Bio Co. | 155.68M | -8.95% | 106,651 | 9.96M |
| 315 | VXRT | Vaxart, Inc. | 154.08M | -1.61% | 1,746,151 | 8.89M |
| 316 | ELEV | Elevation Oncology, Inc. | 152.99M | -2.10% | 742,304 | - |
| 317 | DRTS | Alpha Tau Medical Ltd. | 152.16M | -14.17% | 88,551 | - |
| 318 | SCPH | scPharmaceuticals Inc. | 151.79M | -2.55% | 154,886 | 17.63M |
| 319 | CGEN | Compugen Ltd. | 151.31M | -3.43% | 144,820 | - |
| 320 | CAPR | Capricor Therapeutics, Inc. | 150.94M | -2.48% | 226,428 | 27.10M |
| 321 | VTYX | Ventyx Biosciences, Inc. | 150.87M | -5.31% | 622,837 | - |
| 322 | VIGL | Vigil Neuroscience, Inc. | 150.53M | -8.35% | 406,295 | - |
| 323 | PBYI | Puma Biotechnology, Inc. | 149.54M | -5.49% | 846,865 | 226.63M |
| 324 | IVA | Inventiva S.A. | 149.26M | -6.25% | 4,630 | 25.74M |
| 325 | RIGL | Rigel Pharmaceuticals, Inc. | 147.84M | 0.12% | 140,679 | 120.35M |
| 326 | ATOS | Atossa Therapeutics, Inc. | 145.88M | -3.33% | 1,001,547 | - |
| 327 | CRBU | Caribou Biosciences, Inc. | 144.51M | 0.63% | 1,662,915 | 33.40M |
| 328 | MDWD | MediWound Ltd. | 144.45M | 1.10% | 79,733 | 19.85M |
| 329 | ADVM | Adverum Biotechnologies, Inc. | 141.98M | -1.87% | 181,847 | - |
| 330 | GALT | Galectin Therapeutics Inc. | 141.70M | -2.98% | 152,869 | - |
| 331 | VERU | Veru Inc. | 139.59M | 8.52% | 1,814,254 | 13.48M |
| 332 | CNTX | Context Therapeutics Inc. | 138.00M | 1.66% | 115,364 | - |
| 333 | RPTX | Repare Therapeutics Inc. | 137.52M | -2.70% | 93,194 | 97.86M |
| 334 | ABOS | Acumen Pharmaceuticals, Inc. | 136.38M | -4.82% | 274,942 | - |
| 335 | FBLG | FibroBiologics, Inc. | 135.46M | 3.50% | 311,427 | - |
| 336 | PRQR | ProQR Therapeutics N.V. | 134.33M | -0.30% | 50,902 | 14.66M |
| 337 | SYRS | Syros Pharmaceuticals, Inc. | 133.64M | 1.42% | 49,614 | 6.98M |
| 338 | ADAG | Adagene Inc. | 131.91M | -1.64% | 1,102 | 18.11M |
| 339 | IVVD | Invivyd, Inc. | 131.25M | -8.33% | 310,075 | - |
| 340 | CRVO | CervoMed Inc. | 130.82M | -1.67% | 26,120 | 6.36M |
| 341 | GTHX | G1 Therapeutics, Inc. | 128.09M | -0.81% | 607,920 | 84.04M |
| 342 | CLLS | Cellectis S.A. | 125.41M | -2.33% | 14,207 | 12.13M |
| 343 | IMAB | I-Mab | 121.70M | -2.47% | 146,104 | 3.90M |
| 344 | CMPX | Compass Therapeutics, Inc. | 121.08M | -6.93% | 286,660 | - |
| 345 | TELO | Telomir Pharmaceuticals, Inc. | 119.92M | -4.71% | 25,404 | - |
| 346 | NVCT | Nuvectis Pharma, Inc. | 119.50M | 5.34% | 80,772 | - |
| 347 | TVGN | Tevogen Bio Holdings Inc. | 118.82M | -2.87% | 49,410 | - |
| 348 | AMLX | Amylyx Pharmaceuticals, Inc. | 118.33M | -7.45% | 1,754,865 | 398.00M |
| 349 | KOD | Kodiak Sciences Inc. | 117.68M | -5.49% | 182,714 | - |
| 350 | RGLS | Regulus Therapeutics Inc. | 115.22M | -7.37% | 658,041 | - |
| 351 | OMGA | Omega Therapeutics, Inc. | 114.17M | -8.00% | 320,095 | 4.94M |
| 352 | CRVS | Corvus Pharmaceuticals, Inc. | 111.34M | -3.78% | 130,261 | - |
| 353 | PDSB | PDS Biotechnology Corporation | 108.20M | -2.64% | 725,437 | - |
| 354 | LSB | LakeShore Biopharma Co Ltd. | 107.27M | -6.24% | 25,325 | - |
| 355 | SEER | Seer, Inc. | 106.50M | -2.96% | 738,660 | 15.67M |
| 356 | DMAC | DiaMedica Therapeutics Inc. | 106.30M | -5.08% | 141,151 | - |
| 357 | MCRB | Seres Therapeutics, Inc. | 106.17M | -2.91% | 2,165,469 | 126.85M |
| 358 | ATYR | aTyr Pharma, Inc. | 104.90M | -2.56% | 177,751 | 588.00K |
| 359 | ORMP | Oramed Pharmaceuticals Inc. | 104.62M | 0.59% | 76,369 | 674.00K |
| 360 | ANVS | Annovis Bio, Inc. | 103.67M | 76.09% | 39,033,246 | - |
| 361 | IMUX | Immunic, Inc. | 103.59M | 2.68% | 439,120 | - |
| 362 | CTMX | CytomX Therapeutics, Inc. | 102.85M | -0.75% | 1,465,232 | 119.18M |
| 363 | IFRX | InflaRx N.V. | 101.87M | - | 62,911 | 107.75K |
| 364 | KPTI | Karyopharm Therapeutics Inc. | 99.69M | -1.90% | 2,085,025 | 140.46M |
| 365 | RAPT | RAPT Therapeutics, Inc. | 97.38M | -3.12% | 363,569 | - |
| 366 | ATHA | Athira Pharma, Inc. | 96.59M | 0.40% | 62,480 | - |
| 367 | BOLD | Boundless Bio, Inc. | 95.69M | 2.63% | 42,719 | - |
| 368 | BYSI | BeyondSpring Inc. | 95.11M | -2.07% | 27,436 | 1.75M |
| 369 | SGMT | Sagimet Biosciences Inc. | 93.51M | -7.28% | 601,578 | 2.00M |
| 370 | CRDF | Cardiff Oncology, Inc. | 93.03M | 1.46% | 700,949 | 610.00K |
| 371 | ELDN | Eledon Pharmaceuticals, Inc. | 92.80M | -3.98% | 48,663 | - |
| 372 | ARMP | Armata Pharmaceuticals, Inc. | 92.56M | -6.91% | 1,956 | 4.70M |
| 373 | CTXR | Citius Pharmaceuticals, Inc. | 92.52M | -5.74% | 2,238,990 | - |
| 374 | COYA | Coya Therapeutics, Inc. | 92.09M | -0.82% | 32,981 | 6.13M |
| 375 | CLSD | Clearside Biomedical, Inc. | 91.92M | -0.81% | 90,988 | 8.45M |
| 376 | XFOR | X4 Pharmaceuticals, Inc. | 91.41M | -7.65% | 3,097,419 | - |
| 377 | ACET | Adicet Bio, Inc. | 90.39M | -4.35% | 1,173,921 | - |
| 378 | RLMD | Relmada Therapeutics, Inc. | 90.22M | -2.61% | 44,414 | - |
| 379 | VTGN | VistaGen Therapeutics, Inc. | 89.99M | -6.72% | 72,241 | 1.06M |
| 380 | EPRX | Eupraxia Pharmaceuticals Inc. | 89.77M | 2.02% | 677 | - |
| 381 | HOWL | Werewolf Therapeutics, Inc. | 89.52M | -12.34% | 330,090 | 16.22M |
| 382 | TLSA | Tiziana Life Sciences Ltd | 88.55M | -3.00% | 178,512 | - |
| 383 | CLRB | Cellectar Biosciences, Inc. | 85.32M | -6.67% | 525,188 | - |
| 384 | ALVR | AlloVir, Inc. | 84.53M | 0.68% | 719,675 | - |
| 385 | ASMB | Assembly Biosciences, Inc. | 82.32M | 0.83% | 12,976 | - |
| 386 | PLX | Protalix BioTherapeutics, Inc. | 82.11M | -4.27% | 578,328 | 59.65M |
| 387 | BNTC | Benitec Biopharma Inc. | 81.50M | 17.73% | 58,093 | 7.00K |
| 388 | PMVP | PMV Pharmaceuticals, Inc. | 80.77M | -0.63% | 355,772 | - |
| 389 | IKNA | Ikena Oncology, Inc. | 78.66M | -1.21% | 201,766 | 3.85M |
| 390 | AFMD | Affimed N.V. | 78.50M | -4.71% | 144,177 | 4.26M |
| 391 | IOBT | IO Biotech, Inc. | 77.74M | 5.36% | 81,157 | - |
| 392 | CMRX | Chimerix, Inc. | 77.31M | -0.75% | 244,276 | 41.00K |
| 393 | CKPT | Checkpoint Therapeutics, Inc. | 77.00M | 3.90% | 387,237 | 68.00K |
| 394 | CNTB | Connect Biopharma Holdings Limited | 76.04M | -4.17% | 18,559 | - |
| 395 | ONCY | Oncolytics Biotech Inc. | 75.09M | -0.52% | 180,693 | - |
| 396 | ALLK | Allakos Inc. | 74.43M | -4.46% | 756,169 | - |
| 397 | VSTM | Verastem, Inc. | 74.33M | -9.69% | 390,044 | - |
| 398 | DBVT | DBV Technologies S.A. | 74.28M | -6.89% | 50,448 | 14.94M |
| 399 | FGEN | FibroGen, Inc. | 73.91M | -3.52% | 3,570,544 | 167.49M |
| 400 | MAIA | MAIA Biotechnology, Inc. | 73.15M | -2.62% | 152,774 | - |
| 401 | CGTX | Cognition Therapeutics, Inc. | 72.91M | 8.98% | 630,168 | - |
| 402 | ANIX | Anixa Biosciences, Inc. | 72.65M | 2.25% | 32,295 | - |
| 403 | CASI | CASI Pharmaceuticals, Inc. | 72.50M | 0.19% | 86,361 | 33.88M |
| 404 | MIST | Milestone Pharmaceuticals Inc. | 71.90M | - | 89,455 | - |
| 405 | SPRO | Spero Therapeutics, Inc. | 70.45M | 1.95% | 34,294 | 110.98M |
| 406 | KRON | Kronos Bio, Inc. | 70.31M | 4.46% | 230,281 | 7.59M |
| 407 | MNOV | MediciNova, Inc. | 68.66M | -2.78% | 11,047 | 1.00M |
| 408 | CELU | Celularity Inc. | 67.64M | -2.66% | 32,931 | 14.79M |
| 409 | SER | Serina Therapeutics Inc | 67.31M | -7.83% | 35,134 | 3.15M |
| 410 | INTS | Intensity Therapeutics, Inc. | 66.78M | -1.02% | 2,586 | - |
| 411 | VANI | Vivani Medical, Inc. | 66.52M | -3.20% | 64,185 | - |
| 412 | SGMO | Sangamo Therapeutics, Inc. | 66.42M | -3.00% | 2,559,370 | 18.76M |
| 413 | CSBR | Champions Oncology, Inc. | 66.07M | -4.71% | 2,099 | 49.22M |
| 414 | MRNS | Marinus Pharmaceuticals, Inc. | 65.37M | -7.03% | 814,406 | 28.29M |
| 415 | TIL | Instil Bio, Inc. | 65.30M | -2.52% | 3,039 | - |
| 416 | DTIL | Precision BioSciences, Inc. | 65.17M | -4.85% | 59,938 | 57.53M |
| 417 | NTRB | Nutriband Inc. | 65.00M | -1.67% | 34,568 | 2.02M |
| 418 | CDT | Conduit Pharmaceuticals Inc. | 64.92M | -11.64% | 49,202 | - |
| 419 | SLS | SELLAS Life Sciences Group, Inc. | 64.69M | -5.08% | 567,314 | - |
| 420 | LPTX | Leap Therapeutics, Inc. | 64.67M | -9.63% | 160,122 | - |
| 421 | ANEB | Anebulo Pharmaceuticals, Inc. | 64.57M | -8.12% | 16,535 | - |
| 422 | THTX | Theratechnologies Inc. | 64.14M | - | 7,749 | 57.85M |
| 423 | ANTX | AN2 Therapeutics, Inc. | 63.54M | - | 36,399 | - |
| 424 | BCAB | BioAtla, Inc. | 63.51M | -2.22% | 919,832 | - |
| 425 | VOR | Vor Biopharma Inc. | 62.39M | -7.61% | 359,976 | - |
| 426 | GRTS | Gritstone bio, Inc. | 62.21M | -1.21% | 1,950,819 | 15.65M |
| 427 | ANL | Adlai Nortye Ltd. | 61.76M | 2.16% | 18,518 | 5.00M |
| 428 | PASG | Passage Bio, Inc. | 61.62M | 12.95% | 160,707 | - |
| 429 | ENTX | Entera Bio Ltd. | 61.25M | -2.84% | 68,618 | - |
| 430 | CARM | Carisma Therapeutics, Inc. | 59.82M | -13.77% | 1,445,481 | 15.07M |
| 431 | ALRN | Aileron Therapeutics, Inc. | 59.59M | -1.43% | 12,803 | - |
| 432 | CVM | CEL-SCI Corporation | 59.03M | -3.54% | 172,562 | - |
| 433 | GNLX | Genelux Corporation | 58.74M | -7.07% | 201,185 | 8.00K |
| 434 | CLGN | CollPlant Biotechnologies Ltd. | 56.81M | -0.40% | 5,805 | 10.62M |
| 435 | GNTA | Genenta Science S.p.A. | 56.36M | 0.45% | 665 | - |
| 436 | HOOK | HOOKIPA Pharma Inc. | 56.15M | -7.43% | 419,169 | 53.55M |
| 437 | BRNS | Barinthus Biotherapeutics plc | 55.84M | 1.41% | 26,669 | 334.00K |
| 438 | OVID | Ovid Therapeutics Inc. | 54.87M | -10.30% | 762,687 | 473.54K |
| 439 | CDTX | Cidara Therapeutics, Inc. | 54.42M | -0.91% | 25,241 | 46.38M |
| 440 | TSBX | Turnstone Biologics Corp. | 53.43M | -12.83% | 277,660 | 19.31M |
| 441 | CUE | Cue Biopharma, Inc. | 52.53M | 5.88% | 566,470 | 7.02M |
| 442 | ABIO | ARCA biopharma, Inc. | 52.37M | -5.00% | 134,951 | - |
| 443 | IMMX | Immix Biopharma, Inc. | 51.77M | -7.55% | 129,486 | - |
| 444 | MURA | Mural Oncology plc | 51.62M | -1.93% | 175,550 | - |
| 445 | RPHM | Reneo Pharmaceuticals, Inc. | 50.47M | -2.58% | 124,303 | - |
| 446 | RLYB | Rallybio Corporation | 49.74M | -11.76% | 714,775 | - |
| 447 | LVTX | LAVA Therapeutics N.V. | 49.69M | - | 53,044 | 13.63M |
| 448 | LTRN | Lantern Pharma Inc. | 47.34M | -2.65% | 20,923 | - |
| 449 | TPST | Tempest Therapeutics, Inc. | 47.10M | -0.93% | 521,475 | - |
| 450 | MRKR | Marker Therapeutics, Inc. | 46.74M | -1.87% | 25,420 | 3.32M |
| 451 | AVTE | Aerovate Therapeutics, Inc. | 46.69M | -4.71% | 764,993 | - |
| 452 | BLRX | BioLineRx Ltd. | 46.12M | -5.18% | 393,903 | 11.66M |
| 453 | VTVT | vTv Therapeutics Inc. | 44.47M | 3.04% | 44,884 | 1.00M |
| 454 | CLNN | Clene Inc. | 42.51M | -7.28% | 573,120 | 620.00K |
| 455 | DYAI | Dyadic International, Inc. | 42.39M | -5.23% | 43,374 | 2.26M |
| 456 | BTAI | BioXcel Therapeutics, Inc. | 42.03M | -4.27% | 463,553 | 1.76M |
| 457 | NXTC | NextCure, Inc. | 41.96M | - | 260,428 | - |
| 458 | TARA | Protara Therapeutics, Inc. | 41.80M | -2.87% | 65,304 | - |
| 459 | KZR | Kezar Life Sciences, Inc. | 41.50M | -2.33% | 890,085 | 7.00M |
| 460 | LPCN | Lipocine Inc. | 40.43M | -2.07% | 33,744 | 4.71M |
| 461 | MLEC | Moolec Science SA | 40.38M | -3.15% | 7,630 | 5.01M |
| 462 | OKYO | OKYO Pharma Limited | 40.22M | -2.42% | 7,021 | - |
| 463 | OCUP | Ocuphire Pharma, Inc. | 40.18M | -2.52% | 72,214 | 19.01M |
| 464 | EYEN | Eyenovia, Inc. | 40.02M | 9.41% | 809,167 | 8.78K |
| 465 | ESLA | Estrella Immunopharma, Inc. | 39.65M | -1.80% | 7,027 | - |
| 466 | AEON | AEON Biopharma, Inc. | 39.51M | -2.88% | 19,902 | - |
| 467 | MTNB | Matinas BioPharma Holdings, Inc. | 39.43M | -2.18% | 519,247 | - |
| 468 | OCEA | Ocean Biomedical, Inc. | 38.11M | -6.78% | 151,110 | - |
| 469 | LEXX | Lexaria Bioscience Corp. | 37.53M | -5.07% | 123,286 | 386.00K |
| 470 | ATRA | Atara Biotherapeutics, Inc. | 36.88M | -10.05% | 92,973 | 34.70M |
| 471 | CRIS | Curis, Inc. | 36.84M | -2.04% | 33,100 | 9.81M |
| 472 | INAB | IN8bio, Inc. | 35.67M | -0.59% | 196,181 | - |
| 473 | ELTX | Elicio Therapeutics, Inc. | 34.82M | -10.32% | 92,863 | - |
| 474 | ACHL | Achilles Therapeutics plc | 34.25M | 3.95% | 45,061 | - |
| 475 | ACXP | Acurx Pharmaceuticals, Inc. | 34.18M | 0.93% | 50,192 | - |
| 476 | FBIO | Fortress Biotech, Inc. | 34.09M | -1.18% | 109,072 | 85.11M |
| 477 | EVGN | Evogene Ltd. | 33.89M | 3.96% | 82,211 | 9.19M |
| 478 | XLO | Xilio Therapeutics, Inc. | 32.85M | -3.67% | 366,168 | - |
| 479 | SRZN | Surrozen, Inc. | 32.69M | -4.49% | 2,083 | - |
| 480 | AADI | Aadi Bioscience, Inc. | 32.41M | -7.04% | 523,820 | 23.84M |
| 481 | IMRX | Immuneering Corporation | 32.32M | -6.84% | 590,043 | - |
| 482 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 32.20M | -9.24% | 204,465 | - |
| 483 | ICCC | ImmuCell Corporation | 32.03M | -8.69% | 4,885 | 21.28M |
| 484 | QNCX | Quince Therapeutics, Inc. | 31.87M | 1.72% | 52,148 | - |
| 485 | PMN | ProMIS Neurosciences, Inc. | 31.48M | 9.21% | 4,752 | - |
| 486 | NKGN | NKGen Biotech, Inc. | 31.18M | -4.72% | 39,682 | - |
| 487 | INKT | MiNK Therapeutics, Inc. | 30.91M | -2.83% | 19,318 | - |
| 488 | DARE | Daré Bioscience, Inc. | 30.58M | -4.22% | 44,523 | 2.82M |
| 489 | PTN | Palatin Technologies, Inc. | 30.34M | 1.08% | 70,895 | 5.90M |
| 490 | ALGS | Aligos Therapeutics, Inc. | 30.01M | 8.40% | 362,195 | 13.79M |
| 491 | PLUR | Pluri Inc. | 29.75M | 0.36% | 3,100 | 341.00K |
| 492 | ORGS | Orgenesis Inc. | 29.65M | -3.19% | 20,425 | 529.00K |
| 493 | LSTA | Lisata Therapeutics, Inc. | 28.74M | -2.54% | 16,788 | - |
| 494 | BOLT | Bolt Biotherapeutics, Inc. | 28.02M | 0.42% | 40,576 | 11.32M |
| 495 | NRXP | NRx Pharmaceuticals, Inc. | 27.82M | 0.78% | 34,993 | - |
| 496 | ENLV | Enlivex Therapeutics Ltd. | 27.59M | -4.20% | 63,938 | - |
| 497 | ICU | SeaStar Medical Holding Corporation | 27.58M | -5.03% | 217,851 | - |
| 498 | IPA | ImmunoPrecise Antibodies Ltd. | 27.37M | 4.04% | 49,352 | 17.67M |
| 499 | RNXT | RenovoRx, Inc. | 27.07M | -1.74% | 20,296 | - |
| 500 | ACST | Acasti Pharma Inc. | 26.79M | -1.38% | 6,678 | - |
| 501 | NRBO | NeuroBo Pharmaceuticals, Inc. | 26.53M | 3.08% | 61,286 | - |
| 502 | SABS | SAB Biotherapeutics, Inc. | 26.40M | -5.92% | 7,278 | 2.60M |
| 503 | VYNE | VYNE Therapeutics Inc. | 26.30M | -5.73% | 28,447 | 423.00K |
| 504 | SLGL | Sol-Gel Technologies Ltd. | 25.61M | 5.90% | 19,003 | 1.72M |
| 505 | BCLI | Brainstorm Cell Therapeutics Inc. | 25.30M | -1.12% | 324,073 | - |
| 506 | BIVI | BioVie Inc. | 24.75M | -2.86% | 265,573 | - |
| 507 | PHGE | BiomX Inc. | 24.54M | 3.05% | 90,384 | - |
| 508 | COCP | Cocrystal Pharma, Inc. | 24.01M | -1.26% | 31,696 | - |
| 509 | EQ | Equillium, Inc. | 23.97M | 0.31% | 94,223 | 37.89M |
| 510 | HCWB | HCW Biologics Inc. | 23.45M | -7.46% | 24,027 | 1.16M |
| 511 | GDTC | CytoMed Therapeutics Limited | 23.43M | -0.49% | 795 | - |
| 512 | NRSN | NeuroSense Therapeutics Ltd. | 22.37M | 14.81% | 2,507,300 | - |
| 513 | UBX | Unity Biotechnology, Inc. | 21.99M | -1.50% | 29,600 | - |
| 514 | BIOR | Biora Therapeutics, Inc. | 21.89M | -3.18% | 200,237 | 544.00K |
| 515 | VINC | Vincerx Pharma, Inc. | 21.77M | -2.94% | 275,169 | - |
| 516 | SPRB | Spruce Biosciences, Inc. | 21.70M | -0.68% | 256,378 | 10.13M |
| 517 | GANX | Gain Therapeutics, Inc. | 21.57M | 6.70% | 266,307 | - |
| 518 | AKTX | Akari Therapeutics, Plc | 21.56M | -4.62% | 23,783 | - |
| 519 | NERV | Minerva Neurosciences, Inc. | 21.54M | -3.75% | 3,765 | - |
| 520 | APLM | Apollomics, Inc. | 21.09M | -1.73% | 113,701 | - |
| 521 | NNVC | NanoViricides, Inc. | 21.03M | -3.78% | 208,525 | - |
| 522 | ONCT | Oncternal Therapeutics, Inc. | 20.87M | 2.62% | 15,125 | 1.15M |
| 523 | APM | Aptorum Group Limited | 20.83M | -0.74% | 39,601 | 431.38K |
| 524 | APRE | Aprea Therapeutics, Inc. | 20.63M | -6.17% | 6,160 | 963.80K |
| 525 | AIM | AIM ImmunoTech Inc. | 20.59M | -3.56% | 106,793 | 193.00K |
| 526 | VBIV | VBI Vaccines Inc. | 20.39M | 2.75% | 383,350 | 9.41M |
| 527 | VIRX | Viracta Therapeutics, Inc. | 19.24M | -3.92% | 106,534 | - |
| 528 | FBRX | Forte Biosciences, Inc. | 19.09M | -4.05% | 10,036 | - |
| 529 | NRXS | NeurAxis, Inc. | 19.08M | 1.77% | 4,563 | 2.30M |
| 530 | KALA | Kala Pharmaceuticals, Inc. | 18.90M | -2.61% | 117,904 | - |
| 531 | MEIP | MEI Pharma, Inc. | 18.66M | -1.75% | 44,603 | 66.75M |
| 532 | BCTX | BriaCell Therapeutics Corp. | 18.47M | -7.34% | 53,416 | - |
| 533 | INDP | Indaptus Therapeutics, Inc. | 18.44M | 10.41% | 496 | - |
| 534 | LUMO | Lumos Pharma, Inc. | 18.42M | -3.40% | 12,192 | 1.53M |
| 535 | UNCY | Unicycive Therapeutics, Inc. | 18.05M | -11.11% | 648,302 | - |
| 536 | ITRM | Iterum Therapeutics plc | 18.04M | -0.91% | 83,657 | - |
| 537 | SNTI | Senti Biosciences, Inc. | 17.84M | -6.59% | 8,636,945 | 1.28M |
| 538 | ATHE | Alterity Therapeutics Limited | 17.56M | 1.12% | 4,703 | - |
| 539 | PMCB | PharmaCyte Biotech, Inc. | 17.41M | 3.00% | 9,785 | - |
| 540 | GLYC | GlycoMimetics, Inc. | 17.33M | -9.22% | 1,076,921 | 10.00K |
| 541 | LYRA | Lyra Therapeutics, Inc. | 17.07M | -5.69% | 1,050,767 | 1.68M |
| 542 | MBIO | Mustang Bio, Inc. | 17.00M | 15.40% | 20,638,903 | - |
| 543 | IBIO | iBio, Inc. | 16.82M | -2.99% | 98,765 | 50.00K |
| 544 | SYBX | Synlogic, Inc. | 16.74M | -4.03% | 13,745 | 3.21M |
| 545 | JAGX | Jaguar Health, Inc. | 16.67M | -2.01% | 424,133 | 10.14M |
| 546 | SNSE | Sensei Biotherapeutics, Inc. | 15.80M | 5.90% | 26,745 | - |
| 547 | CARA | Cara Therapeutics, Inc. | 15.19M | 5.67% | 653,829 | 16.94M |
| 548 | EVAX | Evaxion Biotech A/S | 15.12M | 1.94% | 5,441 | 73.00K |
| 549 | KTRA | Kintara Therapeutics, Inc. | 14.33M | -12.91% | 5,593,443 | - |
| 550 | EDSA | Edesa Biotech, Inc. | 13.54M | -3.88% | 3,376 | - |
| 551 | AEZS | Aeterna Zentaris Inc. | 13.50M | -6.17% | 2,418 | 4.50M |
| 552 | APTO | Aptose Biosciences Inc. | 13.46M | -0.52% | 13,827 | - |
| 553 | CANF | Can-Fite BioPharma Ltd. | 13.25M | -8.05% | 93,420 | 743.00K |
| 554 | KPRX | Kiora Pharmaceuticals, Inc. | 13.19M | 2.07% | 11,520 | 16.00M |
| 555 | XTLB | XTL Biopharmaceuticals Ltd. | 13.04M | -2.99% | 3,700 | - |
| 556 | CMMB | Chemomab Therapeutics Ltd. | 13.02M | 0.31% | 5,366 | - |
| 557 | BRTX | BioRestorative Therapies, Inc. | 13.00M | -3.03% | 58,123 | 149.50K |
| 558 | CLDI | Calidi Biotherapeutics, Inc. | 12.99M | 4.87% | 631,198 | - |
| 559 | AVTX | Avalo Therapeutics, Inc. | 12.68M | 1.74% | 4,201 | 1.45M |
| 560 | MNPR | Monopar Therapeutics Inc. | 12.59M | -2.89% | 45,273 | - |
| 561 | GLTO | Galecto, Inc. | 12.51M | -0.99% | 58,853 | - |
| 562 | IMRN | Immuron Limited | 12.32M | -0.87% | 2,887 | 2.43M |
| 563 | CDIO | Cardio Diagnostics Holdings, Inc. | 12.26M | 0.09% | 84,146 | 32.99K |
| 564 | ADXN | Addex Therapeutics Ltd | 12.11M | -4.27% | 3,472 | 1.57M |
| 565 | DOMH | Dominari Holdings Inc. | 11.81M | 6.99% | 24,612 | 3.41M |
| 566 | IMNN | Imunon, Inc. | 11.66M | -1.59% | 11,432 | - |
| 567 | PPBT | Purple Biotech Ltd. | 11.52M | 2.92% | 304,290 | - |
| 568 | PIRS | Pieris Pharmaceuticals, Inc. | 11.31M | -11.65% | 32,823 | 40.93M |
| 569 | ELAB | Elevai Labs, Inc. | 10.81M | -4.35% | 32,785 | 2.18M |
| 570 | ONVO | Organovo Holdings, Inc. | 10.78M | -1.25% | 21,719 | 109.00K |
| 571 | LGVN | Longeveron Inc. | 10.67M | 7.01% | 1,509,173 | 978.00K |
| 572 | VCNX | Vaccinex, Inc. | 10.58M | 2.77% | 49,760 | 124.00K |
| 573 | COEP | Coeptis Therapeutics, Inc. | 10.21M | -3.10% | 44,223 | - |
| 574 | TCRT | Alaunos Therapeutics, Inc. | 10.09M | -3.21% | 22,451 | 5.00K |
| 575 | ERNA | Eterna Therapeutics Inc. | 9.63M | -5.82% | 4,564 | 115.00K |
| 576 | TRAW | Traws Pharma, Inc. | 9.23M | -15.31% | 291,043 | 226.00K |
| 577 | ABVC | ABVC BioPharma, Inc. | 9.08M | -8.06% | 72,032 | 25.36K |
| 578 | PSTV | Plus Therapeutics, Inc. | 8.84M | 3.33% | 18,095 | 6.08M |
| 579 | IKT | Inhibikase Therapeutics, Inc. | 8.73M | -3.20% | 14,773 | 195.98K |
| 580 | BNOX | Bionomics Limited | 8.41M | 2.54% | 58,027 | 15.00K |
| 581 | NLSP | NLS Pharmaceutics AG | 8.41M | 1.88% | 6,576,365 | - |
| 582 | GOVX | GeoVax Labs, Inc. | 8.37M | 0.91% | 1,952,833 | - |
| 583 | MBRX | Moleculin Biotech, Inc. | 8.25M | -2.46% | 2,971 | - |
| 584 | FRES | Fresh2 Group Ltd | 8.08M | -2.91% | 18,956 | 2.35M |
| 585 | CVKD | Cadrenal Therapeutics, Inc. | 7.76M | 2.11% | 93,927 | - |
| 586 | MTEM | Molecular Templates, Inc. | 7.64M | -3.33% | 59,938 | 31.76M |
| 587 | CHRO | Chromocell Therapeutics Corporation | 7.32M | 1.60% | 3,087 | - |
| 588 | PULM | Pulmatrix, Inc. | 7.30M | 2.56% | 71,115 | 11.68M |
| 589 | KA | Kineta, Inc. | 7.23M | 2.25% | 68,577 | 5.16M |
| 590 | PYPD | PolyPid Ltd. | 6.61M | -5.88% | 2,231 | - |
| 591 | VIRI | Virios Therapeutics, Inc. | 6.50M | 5.41% | 629,108 | - |
| 592 | ASLN | ASLAN Pharmaceuticals Limited | 6.36M | -6.33% | 195,307 | 12.00M |
| 593 | XBIO | Xenetic Biosciences, Inc. | 6.32M | 1.49% | 10,301 | 2.44M |
| 594 | CYCN | Cyclerion Therapeutics, Inc. | 6.30M | 1.32% | 2,822 | - |
| 595 | GTBP | GT Biopharma, Inc. | 6.21M | 8.27% | 37,329 | - |
| 596 | TENX | Tenax Therapeutics, Inc. | 6.21M | 7.82% | 54,895 | - |
| 597 | RNAZ | TransCode Therapeutics, Inc. | 6.18M | -1.07% | 103,999 | - |
| 598 | OGEN | Oragenics, Inc. | 5.69M | -3.78% | 48,999 | 20.63K |
| 599 | HEPA | Hepion Pharmaceuticals, Inc. | 5.69M | -1.89% | 4,502 | - |
| 600 | NTBL | Notable Labs, Ltd. | 5.62M | -1.47% | 61,703 | 311.00K |
| 601 | ALLR | Allarity Therapeutics, Inc. | 5.55M | -4.32% | 1,658,533 | - |
| 602 | PCSA | Processa Pharmaceuticals, Inc. | 5.52M | -8.96% | 21,682 | - |
| 603 | TFFP | TFF Pharmaceuticals, Inc. | 5.51M | - | 20,691 | 885.72K |
| 604 | KTTA | Pasithea Therapeutics Corp. | 5.38M | -0.29% | 2,465 | - |
| 605 | BCDA | BioCardia, Inc. | 5.35M | -1.67% | 31,300 | 468.00K |
| 606 | NCNA | NuCana plc | 5.31M | -4.46% | 6,344 | - |
| 607 | LIXT | Lixte Biotechnology Holdings, Inc. | 5.29M | -4.07% | 5,494 | - |
| 608 | TNXP | Tonix Pharmaceuticals Holding Corp. | 5.16M | 0.68% | 2,412,909 | 10.25M |
| 609 | XRTX | XORTX Therapeutics Inc. | 5.12M | -5.78% | 2,982 | - |
| 610 | KZIA | Kazia Therapeutics Limited | 5.06M | -1.15% | 139,312 | 15.65K |
| 611 | CMND | Clearmind Medicine Inc. | 5.01M | -4.82% | 684,030 | - |
| 612 | CELZ | Creative Medical Technology Holdings, Inc. | 4.97M | -1.47% | 4,510 | 9.00K |
| 613 | TTNP | Titan Pharmaceuticals, Inc. | 4.96M | -1.99% | 682 | 87.00K |
| 614 | SNPX | Synaptogenix, Inc. | 4.96M | -0.74% | 10,763 | - |
| 615 | DRUG | Bright Minds Biosciences Inc. | 4.91M | 4.76% | 3,883 | - |
| 616 | HOTH | Hoth Therapeutics, Inc. | 4.73M | -6.06% | 18,995 | - |
| 617 | ADIL | Adial Pharmaceuticals, Inc. | 4.40M | -4.59% | 115,393 | - |
| 618 | MYMD | MyMD Pharmaceuticals, Inc. | 4.32M | -2.51% | 9,816 | - |
| 619 | ENVB | Enveric Biosciences, Inc. | 4.28M | -7.81% | 132,211 | - |
| 620 | ARTL | Artelo Biosciences, Inc. | 4.26M | -4.35% | 21,339 | - |
| 621 | PALI | Palisade Bio, Inc. | 4.25M | 5.09% | 8,180 | - |
| 622 | GNPX | Genprex, Inc. | 4.13M | 3.68% | 20,662 | - |
| 623 | CERO | CERo Therapeutics Holdings, Inc. | 4.05M | -2.08% | 872,744 | - |
| 624 | TOVX | Theriva Biologics, Inc. | 3.97M | -4.68% | 74,854 | - |
| 625 | BPTH | Bio-Path Holdings, Inc. | 3.87M | -4.12% | 49,889 | - |
| 626 | ONCO | Onconetix, Inc. | 3.86M | 10.06% | 2,426,059 | 758.90K |
| 627 | TRVN | Trevena, Inc. | 3.77M | -2.10% | 371,468 | 3.14M |
| 628 | ENSC | Ensysce Biosciences, Inc. | 3.61M | -3.59% | 75,204 | - |
| 629 | SILO | Silo Pharma, Inc. | 3.48M | -2.39% | 34,286 | 72.10K |
| 630 | LIPO | Lipella Pharmaceuticals Inc. | 3.48M | -3.51% | 12,571 | 477.45K |
| 631 | PRTG | Portage Biotech Inc. | 3.46M | -7.60% | 298,920 | - |
| 632 | PTIX | Protagenic Therapeutics, Inc. | 3.41M | -18.62% | 53,711 | - |
| 633 | NEXI | NexImmune, Inc. | 3.40M | -4.25% | 8,118 | - |
| 634 | ATXI | Avenue Therapeutics, Inc. | 3.21M | -2.57% | 15,538 | - |
| 635 | ALZN | Alzamend Neuro, Inc. | 3.12M | -3.41% | 51,832 | - |
| 636 | ZVSA | ZyVersa Therapeutics, Inc. | 2.95M | -2.22% | 7,702 | - |
| 637 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.93M | -6.94% | 145,797 | 569.86K |
| 638 | REVB | Revelation Biosciences, Inc. | 2.92M | -4.28% | 33,149 | - |
| 639 | ADTX | Aditxt, Inc. | 2.92M | -7.28% | 13,292 | 506.44K |
| 640 | TCBP | TC Biopharm (Holdings) Plc | 2.85M | 6.74% | 52,020 | - |
| 641 | PHIO | Phio Pharmaceuticals Corp. | 2.80M | -9.45% | 232,880 | - |
| 642 | ENTO | Entero Therapeutics, Inc. | 2.78M | -14.77% | 208,485 | - |
| 643 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 2.74M | -5.54% | 67,839 | 92.73K |
| 644 | CYTO | Altamira Therapeutics Ltd. | 2.73M | - | 61,651 | - |
| 645 | XCUR | Exicure, Inc. | 2.68M | -6.79% | 9,285 | 500.00K |
| 646 | THAR | Tharimmune, Inc. | 2.60M | -6.76% | 6,342 | - |
| 647 | VRAX | Virax Biolabs Group Limited | 2.60M | - | 32,730 | 79.30K |
| 648 | CYCC | Cyclacel Pharmaceuticals, Inc. | 2.43M | 2.47% | 14,059 | 449.00K |
| 649 | NBY | NovaBay Pharmaceuticals, Inc. | 2.35M | -3.13% | 18,108 | 14.23M |
| 650 | CING | Cingulate Inc. | 2.34M | -5.07% | 366,741 | - |
| 651 | SNGX | Soligenix, Inc. | 2.24M | -8.84% | 127,027 | 699.21K |
| 652 | QNRX | Quoin Pharmaceuticals, Ltd. | 2.19M | -3.74% | 86,509 | - |
| 653 | AZTR | Azitra, Inc. | 2.09M | -35.88% | 382,224 | 572.70K |
| 654 | INM | InMed Pharmaceuticals Inc. | 2.07M | -1.51% | 157,095 | 5.63M |
| 655 | SPRC | SciSparc Ltd. | 1.92M | -1.90% | 28,076 | 2.88M |
| 656 | WINT | Windtree Therapeutics, Inc. | 1.84M | -2.80% | 18,244 | - |
| 657 | SCNI | Scinai Immunotherapeutics Ltd. | 1.73M | 1.36% | 31,609 | - |
| 658 | GLMD | Galmed Pharmaceuticals Ltd. | 1.71M | -0.94% | 81,594 | - |
| 659 | SEEL | Seelos Therapeutics, Inc. | 1.66M | -4.70% | 232,955 | 1.97M |
| 660 | ATNF | 180 Life Sciences Corp. | 1.55M | 10.00% | 17,022 | - |
| 661 | VRPX | Virpax Pharmaceuticals, Inc. | 1.45M | 5.81% | 79,056 | - |
| 662 | NBSE | NeuBase Therapeutics, Inc. | 1.42M | -1.56% | 97,744 | - |
| 663 | SLRX | Salarius Pharmaceuticals, Inc. | 1.31M | -0.90% | 15,682 | - |
| 664 | APVO | Aptevo Therapeutics Inc. | 1.22M | -10.78% | 617,300 | - |
| 665 | QLGN | Qualigen Therapeutics, Inc. | 1.12M | -0.30% | 364,690 | - |
| 666 | DRMA | Dermata Therapeutics, Inc. | 990.25K | -5.51% | 21,797 | - |
| 667 | GRI | GRI Bio, Inc. | 990.19K | -13.68% | 310,601 | - |
| 668 | EFTR | eFFECTOR Therapeutics, Inc. | 846.79K | -32.56% | 1,408,362 | - |
| 669 | CNSP | CNS Pharmaceuticals, Inc. | 298.67K | -11.27% | 236,177 | - |
| 670 | BDRX | Biodexa Pharmaceuticals Plc | 212.13K | 0.35% | 630,188 | 482.28K |